Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)

Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)

Neo-chemoradiotherapy (nCRT) before surgery is a standard treatment for locally advanced esophageal cancers. However, the treatment outcome of nCRT varied with different patients. This study aimed to identify potential biomarkers for prediction of nCRT-response in patients with esophageal squamous c...

Full description

Bibliographic Details
Main Authors:	Jian Wang, Pengyi Yu, Judong Luo, Zhiqiang Sun, Jingping Yu, Jianlin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Pharmacology
Subjects:	esophageal neoplasms differentially expressed genes prognosis MMP12 neo-chemoradiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.626972/full

Similar Items

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma
by: Sehhoon Park, et al.
Published: (2019-05-01)

The treatment outcome of definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Mahdi Seilanian Toosi, et al.
Published: (2007-10-01)

Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
by: Qian Wang, et al.
Published: (2021-09-01)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
by: Ying-Ying Xu, et al.
Published: (2021-07-01)

Influence of Chemoradiotherapy Strategies and Factors on the Five-Years Survival of Patients with Esophageal Cancer
by: Seyed Kazem Mirinezhad, et al.
Published: (2014-08-01)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
by: Chih-Yi Chen, et al.
Published: (2018-07-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
by: Takeshi Kawakami, et al.
Published: (2018-05-01)

Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
by: Zhang Y, et al.
Published: (2018-04-01)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
by: Qifeng Wang, et al.
Published: (2020-05-01)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
by: Fujii, Kota
Published: (2021)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
by: Toshiki Ikawa, et al.
Published: (2019-08-01)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
by: Rong Wu, et al.
Published: (2020-10-01)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy
by: Chia-Hsin Lin, et al.
Published: (2020-03-01)

Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
by: Jingzhen Shi, et al.
Published: (2020-07-01)

Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer
by: Xiaomin Ge, et al.
Published: (2018-11-01)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
by: Song T, et al.
Published: (2020-03-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
by: Yang Yang, et al.
Published: (2020-08-01)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
by: Yao‐Hung Kuo, et al.
Published: (2020-01-01)

Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
by: Jingzhen Shi, et al.
Published: (2020-11-01)

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial
by: Xin Wang, et al.
Published: (2020-08-01)

A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
by: Wenjie Ni, et al.
Published: (2020-02-01)

Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes
by: Yilin Yu, et al.
Published: (2021-06-01)

STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma
by: Zhen-Yuan Zheng, et al.
Published: (2021-02-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases
by: Changhyeok Hwang, et al.
Published: (2015-11-01)

Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
by: Chia-Chin Li, et al.
Published: (2021-04-01)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
by: Zongxing Zhao, et al.
Published: (2020-08-01)

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
by: Shau-Hsuan Li, et al.
Published: (2021-06-01)

Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer
by: Lv S, et al.
Published: (2016-09-01)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
by: Dong-Bin Wang, et al.
Published: (2016-01-01)

Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
by: Mingqiu Chen, et al.
Published: (2020-01-01)

Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes
by: Chen M, et al.
Published: (2019-04-01)

Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients
by: Hirotake Saito, et al.
Published: (2018-02-01)